Seek Returns logo

AFRM vs. ALAB: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at AFRM and ALAB, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.

Company Overview

With AFRM at 15.24 billion USD and ALAB at 15.20 billion USD, their market capitalizations sit in the same ballpark.

AFRM’s beta of 3.66 points to much larger expected swings compared to ALAB’s calmer 0.33, suggesting both higher upside and downside potential.

SymbolAFRMALAB
Company NameAffirm Holdings, Inc.Astera Labs, Inc. Common Stock
CountryUSUS
SectorTechnologyTechnology
IndustrySoftware - InfrastructureSemiconductors
CEOMr. Max Roth LevchinMr. Jitendra Mohan
Price47.24 USD92.17 USD
Market Cap15.24 billion USD15.20 billion USD
Beta3.660.33
ExchangeNASDAQNASDAQ
IPO DateJanuary 13, 2021March 20, 2024
ADRNoNo

Performance Comparison

This chart compares the performance of AFRM and ALAB over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of AFRM and ALAB based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

  • AFRM has a negative P/E (-246.14) due to recent losses. In contrast, ALAB commands a premium multiple of 363.38, signaling strong market confidence in its future earnings growth to justify this high valuation.
  • AFRM posts a negative forward PEG of -1.38, hinting at anticipated earnings decline, whereas ALAB at 10.90 has projections for stable or growing earnings.
SymbolAFRMALAB
Price-to-Earnings Ratio (P/E, TTM)-246.14363.38
Forward PEG Ratio (TTM)-1.3810.90
Price-to-Sales Ratio (P/S, TTM)5.0730.99
Price-to-Book Ratio (P/B, TTM)5.3214.44
Price-to-Free Cash Flow Ratio (P/FCF, TTM)25.04140.53
EV-to-EBITDA (TTM)69.85-832.77
EV-to-Sales (TTM)7.0730.81
EV-to-Free Cash Flow (TTM)34.90139.73

Dividend Comparison

Neither AFRM nor ALAB currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.

SymbolAFRMALAB
Dividend Yield (TTM)0.00%0.00%

Financial Strength Metrics Comparison

This section dives into the financial resilience of AFRM and ALAB, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

  • AFRM has negative EBIT (interest coverage -0.24), unable to cover interest, while ALAB shows “--” (negligible interest expense).
SymbolAFRMALAB
Current Ratio (TTM)63.0913.92
Quick Ratio (TTM)63.0913.26
Debt-to-Equity Ratio (TTM)2.560.00
Debt-to-Assets Ratio (TTM)0.710.00
Interest Coverage Ratio (TTM)-0.24--